FEDERICO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 75.063
EU - Europa 34.713
AS - Asia 27.522
SA - Sud America 4.152
Continente sconosciuto - Info sul continente non disponibili 1.723
AF - Africa 767
OC - Oceania 205
Totale 144.145
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 73.429
GB - Regno Unito 11.227
IT - Italia 7.653
SG - Singapore 7.252
CN - Cina 7.008
RU - Federazione Russa 3.661
HK - Hong Kong 3.324
BR - Brasile 3.118
VN - Vietnam 2.985
DE - Germania 2.613
SE - Svezia 2.571
FI - Finlandia 1.731
BD - Bangladesh 1.675
TR - Turchia 1.473
UA - Ucraina 1.450
FR - Francia 1.281
CA - Canada 842
KR - Corea 770
IN - India 593
BG - Bulgaria 546
JP - Giappone 462
NL - Olanda 390
ID - Indonesia 376
AR - Argentina 334
IE - Irlanda 276
MX - Messico 258
IQ - Iraq 208
ZA - Sudafrica 205
ES - Italia 195
AU - Australia 185
AE - Emirati Arabi Uniti 169
PK - Pakistan 167
EC - Ecuador 152
CO - Colombia 147
PL - Polonia 142
BE - Belgio 139
AT - Austria 137
CL - Cile 137
MY - Malesia 137
MA - Marocco 129
BZ - Belize 109
CZ - Repubblica Ceca 105
EG - Egitto 103
SA - Arabia Saudita 100
CH - Svizzera 90
VE - Venezuela 89
CR - Costa Rica 86
PH - Filippine 86
RO - Romania 86
UZ - Uzbekistan 80
JM - Giamaica 76
IR - Iran 75
IL - Israele 69
LT - Lituania 67
TH - Thailandia 67
TN - Tunisia 66
NP - Nepal 63
TW - Taiwan 59
DZ - Algeria 56
KE - Kenya 56
PY - Paraguay 49
PE - Perù 46
JO - Giordania 45
PT - Portogallo 43
AZ - Azerbaigian 41
UY - Uruguay 39
DK - Danimarca 37
TT - Trinidad e Tobago 33
BO - Bolivia 32
GT - Guatemala 31
DO - Repubblica Dominicana 30
HN - Honduras 30
HU - Ungheria 30
NO - Norvegia 30
SV - El Salvador 30
EU - Europa 29
KZ - Kazakistan 28
ET - Etiopia 26
GR - Grecia 26
OM - Oman 26
EE - Estonia 25
PR - Porto Rico 25
KG - Kirghizistan 24
NI - Nicaragua 23
PA - Panama 20
LB - Libano 19
RS - Serbia 19
BH - Bahrain 17
NZ - Nuova Zelanda 17
AL - Albania 16
LY - Libia 16
SK - Slovacchia (Repubblica Slovacca) 16
AM - Armenia 15
HR - Croazia 15
LV - Lettonia 15
MD - Moldavia 15
SI - Slovenia 15
AO - Angola 13
BY - Bielorussia 13
GE - Georgia 13
Totale 142.167
Salva come PNG Salva come JPEG
Città #
Ashburn 8.610
Southend 8.520
Fairfield 6.448
Santa Clara 5.063
Singapore 4.514
Woodbridge 3.561
Hong Kong 3.200
Houston 2.981
Chandler 2.930
San Jose 2.828
Moscow 2.715
Jacksonville 2.649
Seattle 2.456
Wilmington 2.283
Dearborn 2.119
Cambridge 2.087
Hefei 2.032
Council Bluffs 2.012
Ann Arbor 1.640
Beijing 1.421
Nyköping 1.349
Los Angeles 1.316
London 1.314
Helsinki 1.206
Chicago 960
Ho Chi Minh City 895
New York 862
The Dalles 840
Izmir 783
Milan 748
Hanoi 657
Frankfurt am Main 650
San Diego 635
Princeton 597
Seoul 587
Buffalo 550
Sofia 528
Dallas 514
Eugene 477
Modena 474
Rome 437
Lauterbourg 396
Columbus 382
São Paulo 353
Shanghai 347
Salt Lake City 337
Redwood City 308
Phoenix 302
Des Moines 281
Jakarta 263
Atlanta 235
Tokyo 229
Dublin 221
Munich 217
Toronto 211
Boardman 206
Dong Ket 206
Bremen 169
Orem 168
Bologna 167
San Francisco 158
Elk Grove Village 150
Falls Church 144
Brooklyn 142
Denver 142
Naples 137
Miami 134
Tampa 134
Montreal 130
Da Nang 129
Turin 129
North Bergen 127
Philadelphia 123
Haiphong 116
Manchester 116
Verona 111
Norwalk 110
Belize City 106
Las Vegas 104
Rio de Janeiro 103
Warsaw 96
Guangzhou 92
Boston 90
Chennai 89
Florence 87
Nuremberg 86
Washington 85
Brussels 83
Mexico City 83
Padova 83
Palermo 81
Amsterdam 79
Johannesburg 79
Brno 77
Sterling 77
Kunming 74
Stockholm 74
Baghdad 70
Lancaster 70
Miano 69
Totale 95.615
Salva come PNG Salva come JPEG
Nome #
Clinical activity and safety of combination immunotherapy with interferon-(2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma. 2.956
SPLENECTOMY AFTER INITIAL THERAPY WITH ALPHA-IFN IN PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL) - A MULTICENTER STUDY BY THE ITALIAN COOPERATIVE GROUP FOR HCL - PRELIMINARY-RESULTS 2.662
Hb Hasharon: studio di un nucleo familiare 1.527
Eritropoiesi extramidollare intratoracica. Considerazioni clinico radiologiche su due casi di talassemia minor 1.176
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12 1.173
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial 964
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 818
Cancer profile in Eastern Libya: incidence and mortality in the year 2004. 800
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial 789
Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin 778
Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003 765
Estimates of cancer burden in Italy 729
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lmphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi 724
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. 708
Pattern of cancer risk in person with AIDS in Italy inthe HAART era 706
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma 644
IMPACT Working Group: effectiveness of service screening: a case-control study to assess breast cancer mortalità reduction. 621
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 587
Caratterizzazione morfo-funzionale delle cellule reticolari dendritiche. 586
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients 564
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. 558
Il linfoma mantellare 551
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients 544
T-cell lymphoma in South America and Europe. 532
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 516
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project 500
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 499
Transformed follicular lymphoma 498
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women 495
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias. 489
Nonpegylated liposomal doxorubicin (Myocet) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EURO 18 trial 486
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 484
Follicular lymphoma international prognostic index. 459
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 453
Splenic marginal zone lymphoma: a prognostic model for clinical use. 449
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study 448
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma 432
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma - The experience of the gruppo italiano studio linfomi 429
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 428
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions. 423
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy 419
Use of 2-(18F)fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy 413
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations 408
Prognosis and treatment of micrometastatic breast cancer sentinel lymph node: a population-based study. 408
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 404
Revised response criteria for malignant lymphoma. 403
Identification of protein clusters predictive of response to chemotherapy in breast cancer patients 400
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project 393
Protein expression patterns associated with advanced stage ovarian cancer 392
Treatment of indolent B-cell nonfollicular lymphomas: Final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi 391
Patologia non neoplastica del follicolo linfatico 388
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 385
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 385
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. 380
PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract 379
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 379
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience 378
Prognosis of follicular lymphomas 376
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat 376
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy 374
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfom 374
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 368
Ovarian cancer: can proteomics give new insights for therapy and diagnosis? 365
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 364
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 363
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies 363
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: Results from a study of the Fondazione Italiana Linfomi 359
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 357
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study 355
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: Final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi 355
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: Results of a prospective, multicenter study of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 354
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project 354
Anthracyclines: A cornerstone in the management of non-Hodgkin's lymphoma 354
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL) 352
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study 351
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines 350
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma 350
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis 350
Concordance between four European centre of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. 347
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: Results of a large multicenter study involving 990 patients 345
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 344
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi 341
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network 340
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-cell Lymphoma Project 339
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. 338
PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study 338
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 337
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 336
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. 334
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 333
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 332
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. 332
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis 332
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma 331
Bone marrow uptake of liposome-entrapped spin label after liver blockade with empty liposomes 330
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 330
Cancer incidence, mortality, and survival in Eastern Libya: Updated report from the Benghazi Cancer Registry 330
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi 329
Role of Glutathione-S-Transferase (GST) polymorphisms in patients with advanced Hodgkin Lymphoma: results from the HD2000 GISL Trial 328
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project 327
Totale 51.592
Salva come PNG Salva come JPEG
Categoria #
all - tutte 506.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 506.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.304 0 0 0 792 318 521 593 608 1.062 702 1.647 1.061
2022/20239.552 1.028 902 642 808 1.197 1.459 252 1.007 1.215 176 504 362
2023/20247.778 329 432 421 538 1.586 462 810 1.161 160 284 698 897
2024/202520.415 1.371 985 282 1.358 3.603 2.583 1.651 1.112 2.432 716 1.892 2.430
2025/202640.137 2.134 1.579 3.222 3.757 5.055 2.794 4.330 1.997 3.475 3.255 4.296 4.243
2026/20279.567 1.717 2.448 3.079 2.323 0 0 0 0 0 0 0 0
Totale 144.145